APA

Trail P. A., Willner D., Knipe J., Henderson A. J., Lasch S. J., Zoeckler M. E., TrailSmith M. D., Doyle T. W., King H. D., Casazza A. M., Braslawsky G. R., Brown J., Hofstead S. J., Greenfield R. S., Firestone R. A., Mosure K., Kadow K. F., Yang M. B., Hellström K. E. & Hellström I. (19970128). Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. : Cancer research.

Chicago

Trail P A, Willner D, Knipe J, Henderson A J, Lasch S J, Zoeckler M E, TrailSmith M D, Doyle T W, King H D, Casazza A M, Braslawsky G R, Brown J, Hofstead S J, Greenfield R S, Firestone R A, Mosure K, Kadow K F, Yang M B, Hellström K E and Hellström I. 19970128. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. : Cancer research.

Harvard

Trail P. A., Willner D., Knipe J., Henderson A. J., Lasch S. J., Zoeckler M. E., TrailSmith M. D., Doyle T. W., King H. D., Casazza A. M., Braslawsky G. R., Brown J., Hofstead S. J., Greenfield R. S., Firestone R. A., Mosure K., Kadow K. F., Yang M. B., Hellström K. E. and Hellström I. (19970128). Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. : Cancer research.

MLA

Trail P A, Willner D, Knipe J, Henderson A J, Lasch S J, Zoeckler M E, TrailSmith M D, Doyle T W, King H D, Casazza A M, Braslawsky G R, Brown J, Hofstead S J, Greenfield R S, Firestone R A, Mosure K, Kadow K F, Yang M B, Hellström K E and Hellström I. Effect of linker variation on the stability, potency, and efficacy of carcinoma-reactive BR64-doxorubicin immunoconjugates. : Cancer research. 19970128.